 Home > Biochemistry News > Biotechnology News > Eli Lilly reaches cooperation with RNA editing to treat liver and central nervous system diseases

Eli Lilly reaches cooperation with RNA editing to treat liver and central nervous system diseases

 Last Update: 2021-09-20
 Source: Internet
 Author: User

Tags

global company

princeton consumer research

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 8, 2021, ProQR Therapeutics announced that it has reached a global licensing and research cooperation agreement with Eli Lilly and Company

This is after Roche and Shape Therapeutics reached a research and development cooperation of up to US$3 billion at the end of August, RNA editors once again won the favor of large pharmaceutical companies

ProQR's proprietary Axiomer platform technology can edit single nucleotides in RNA in a highly targeted and specific manner

More than 20,000 G to A mutations are known to cause human diseases, and these mutations can be reversed using this new technology

▲RNA editing induced by EONs (Image source: ProQR company official website)

According to the terms of the agreement, ProQR will receive 50 million U.

Reference materials:

[1] ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.